TOKYO -- Japan has requested Swiss pharmaceutical group Roche and other companies to increase production of antigen test kits that can simultaneously determine infection with COVID-19 and seasonal influenza.
In response to the request, companies are taking measures to make 35-40 million doses available this winter, according to a government official, when simultaneous outbreak of COVID and flu are expected.
